|Videos|March 13, 2017
Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer
Author(s)Ursula Matulonis, M.D.
Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.
Advertisement
Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.
PARP inhibitors work by blocking the repair of DNA within cancer cells, which then allows other DNA repair molecules to target the broken DNA strand.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Simple Ways for Patients With Cancer to Start Exercising
2
Anemia Management in Myelofibrosis: Survival and Quality of Life
3
Finding Credible Voices in the Lynch Syndrome Community
4
Rituxan Combinations Show Longer Remissions in Hairy Cell Leukemia
5
